April 28th 2025
The Regeneron SVP details the company’s approach to reaching oncology patients across the planet.
Targeting the Affluent: Differential Access to Targeted Therapies in China
October 19th 2018Disparities in income levels in China continue to drive far-reaching differences in how poorer and richer cancer patients are treated, with recent data suggesting that the differences in access to treatment lead to different outcomes for poorer patients. Peter De Richter reports.
Emerging Collaboration in EU Drug Pricing and Reimbursement: A Beneluxa Case Study
August 22nd 2018Maude Schmidt and Giovanni Saldutti look at the intergovernmental initiatives involving joint price negotiations developed across Europe as the Beneluxa Initiative on Pharmaceutical Policy to explore the outcomes and implications from these alliances.